CID 1213 - Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women After Switching to Fixed Dose Combination of Rilpivirine, Emtricitabine and Tenofovir DF
Phase of Trial: Phase IV
Latest Information Update: 04 Dec 2015
At a glance
- Drugs Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 01 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 05 May 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 15 Sep 2014 Planned End Date changed from 1 Nov 2014 to 1 Dec 2015, as reported by the ClinicalTrials.gov record.